xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207806 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207808 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207805 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207809 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207810 | 417 | Table 4 | Positive-Intermediate | true | 151.6 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207812 | 417 | Table 4 | Positive-Intermediate | true | 370.4 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207813 | 417 | Table 4 | Positive-Intermediate | true | 195.5 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207815 | 417 | Table 4 | Positive-Low | true | 851.8 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207816 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207811 | 417 | Table 4 | Positive-Intermediate | true | 95.6 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16849 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPST | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207814 | 417 | Table 4 | Positive-High | true | 37.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207820 | 417 | Table 2, Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207821 | 417 | Table 3 | Positive-High | true | 9.4 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207823 | 417 | Table 2, Table 4 | Positive-High | true | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207826 | 417 | Table 2, Table 4 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207827 | 417 | Table 3 | Positive-High | true | 5.5 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207829 | 417 | Table 2, Table 4 | Positive-High | true | 3.7 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207830 | 417 | Table 3 | Positive-High | true | 10.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207835 | 417 | Table 3 | Positive-Intermediate | true | 454.6 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207837 | 417 | Table 4 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207817 | 417 | Table 2, Table 3 | Positive-High | true | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16850 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207834 | 417 | Table 4 | Positive-High | true | 23.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207842 | 417 | Table 2 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207838 | 417 | Table 2 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207840 | 417 | Table 2 | Positive-Intermediate | true | 126.6 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207841 | 417 | Table 2 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207844 | 417 | Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207839 | 417 | Table 2 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16851 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYKPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207843 | 417 | Table 2 | Positive-Low | true | 851.8 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207848 | 417 | Table 2 | Positive-High | true | 7.2 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207847 | 417 | Table 2 | Positive-High | true | 0.9 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207846 | 417 | Table 2 | Positive-High | true | 5.8 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207849 | 417 | Table 2 | Positive-High | true | 4.9 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207851 | 417 | Table 2 | Positive-Intermediate | true | 52.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207845 | 417 | Table 2 | Positive-High | true | 8.4 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16853 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSKYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207850 | 417 | Table 2 | Positive-High | true | 27.1 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207856 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207852 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207854 | 417 | Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207855 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207858 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207853 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17352 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FPPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207857 | 417 | Table 3 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207865 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207860 | 417 | Table 3 | Positive-Intermediate | true | 87.8 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207861 | 417 | Table 3 | Positive-High | true | 20.5 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207863 | 417 | Table 3 | Positive-High | true | 24.7 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207859 | 417 | Table 3 | Positive-High | true | 19.3 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207862 | 417 | Table 3 | Positive-Intermediate | true | 58.2 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 17522 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FQPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207864 | 417 | Table 3 | Positive-Intermediate | true | 434.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207866 | 417 | Table 3 | Positive-Intermediate | true | 384.7 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207868 | 417 | Table 3 | Positive-Intermediate | true | 400.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207869 | 417 | Table 3 | Positive-High | true | 17.2 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207871 | 417 | Table 3 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207872 | 417 | Table 3 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207867 | 417 | Table 3 | Positive-High | true | 12.3 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18045 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FTPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207870 | 417 | Table 3 | Positive-High | true | 33.7 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207878 | 417 | Table 3 | Positive-Intermediate | true | 230.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207873 | 417 | Table 3 | Positive-Intermediate | true | 77.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207875 | 417 | Table 3 | Positive-Intermediate | true | 100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207874 | 417 | Table 3 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207876 | 417 | Table 3 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207877 | 417 | Table 3 | Positive-High | true | 6.2 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 18260 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FVPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207879 | 417 | Table 3 | Positive-High | true | 44.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207881 | 417 | Table 2 | Positive-High | true | 5.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207882 | 417 | Table 2 | Positive-High | true | 13.9 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207883 | 417 | Table 2 | Positive-High | true | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207884 | 417 | Table 2 | Positive-High | true | 2.2 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207885 | 417 | Table 2 | Positive-Intermediate | true | 95.9 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207886 | 417 | Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32087 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207880 | 417 | Table 2 | Positive-High | true | 11.7 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207888 | 417 | Table 2 | Positive-Intermediate | true | 86.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207889 | 417 | Table 2 | Positive-High | true | 32.3 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207891 | 417 | Table 2 | Positive-High | true | 12.8 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207887 | 417 | Table 2 | Positive-High | true | 12.5 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207890 | 417 | Table 2 | Positive-High | true | 22.7 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 32216 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | KLVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207892 | 417 | Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207899 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207895 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207896 | 417 | Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207897 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207898 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73599 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YDVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207894 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207900 | 417 | Table 3 | Positive-Intermediate | true | 312.5 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207905 | 417 | Table 3 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207904 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207901 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207903 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 73925 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YFVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207902 | 417 | Table 3 | Positive-Low | true | 833.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207909 | 417 | Table 3 | Positive-High | true | 18.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207906 | 417 | Table 3 | Positive-High | true | 10.3 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207907 | 417 | Table 3 | Positive-High | true | 18.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207911 | 417 | Table 3 | Positive-Low | true | 888.9 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207908 | 417 | Table 3 | Positive-High | true | 15.7 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74394 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YIVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207910 | 417 | Table 3 | Positive-High | true | 4.6 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207912 | 417 | Table 2, Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207914 | 417 | Table 2, Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207918 | 417 | Table 2, Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207916 | 417 | Table 2, Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 74526 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YKVAYQATV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207922 | 417 | Table 3, Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.